Examination of the matched samples (i.e., normal and tumor tissues from the same patients) showed that > 50% of the cases had DDR1 upregulated in tumor tissues compared with matched normal tissues, suggesting that DDR1 is required for cancer development (Fig. 2B). The gene discussed is DDR1; the disease is cancer.